These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 15283304)
21. Evaluation of bioequivalence of highly variable drugs using clinical trial simulations. II: Comparison of single and multiple-dose trials using AUC and Cmax. el-Tahtawy AA; Tozer TN; Harrison F; Lesko L; Williams R Pharm Res; 1998 Jan; 15(1):98-104. PubMed ID: 9487554 [TBL] [Abstract][Full Text] [Related]
22. [New guidelines for the assessment of bioavailability and bioequivalence]. Blume H; Schug B; Tautz J; Erb K Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):548-55. PubMed ID: 15887065 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol. Panchagnula R; Sancheti P; Rungta S; Agrawal S; Kaul CL Pharmacol Res; 2003 Oct; 48(4):383-7. PubMed ID: 12902209 [TBL] [Abstract][Full Text] [Related]
24. Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study. Liao JJ Stat Med; 2005 Mar; 24(6):883-91. PubMed ID: 15558699 [TBL] [Abstract][Full Text] [Related]
25. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300 [TBL] [Abstract][Full Text] [Related]
26. Optimal sampling times in bioequivalence tests. Kong FH; Gonin R J Biopharm Stat; 2000 Feb; 10(1):31-44. PubMed ID: 10709799 [TBL] [Abstract][Full Text] [Related]
27. [Bioequivalence assessment of pioglitazone hydrochloride oral preparation by limited sampling strategy]. Ding JJ; Jiao Z; Li ZD; Shi XJ Yao Xue Xue Bao; 2006 Sep; 41(9):893-8. PubMed ID: 17111840 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers. Cho HY; Moon JD; Lee YB Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438 [TBL] [Abstract][Full Text] [Related]
29. Bioequivalence evaluation of two brands of lisinopril tablets by in vitro comparative dissolution test and in vivo bioequivalence test. Shin MC; Kim JK; Kim CK Arzneimittelforschung; 2008; 58(1):11-7. PubMed ID: 18368945 [TBL] [Abstract][Full Text] [Related]
30. Different truncation methods of AUC between Japan and the EU for bioequivalence assessment: influence on the regulatory judgment. Oishi M; Chiba K; Fukushima T; Tomono Y; Suwa T Drug Metab Pharmacokinet; 2012; 27(6):658-62. PubMed ID: 22673011 [TBL] [Abstract][Full Text] [Related]
32. The bioequivalence of highly variable drugs and drug products. Midha KK; Rawson MJ; Hubbard JW Int J Clin Pharmacol Ther; 2005 Oct; 43(10):485-98. PubMed ID: 16240706 [TBL] [Abstract][Full Text] [Related]
33. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial. Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993 [TBL] [Abstract][Full Text] [Related]
34. A simulation study to evaluate limited sampling strategies to estimate area under the curve of drug concentration versus time following repetitive oral dosing: limited sampling model versus naive trapezoidal method. Kayano Y; Horiuchi I; Mori YI; Ishida K; Saito T; Taguchi M; Hashimoto Y Biol Pharm Bull; 2009 Aug; 32(8):1486-90. PubMed ID: 19652396 [TBL] [Abstract][Full Text] [Related]
35. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions. Elshafeey AH; Elsherbiny MA; Fathallah MM Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850 [TBL] [Abstract][Full Text] [Related]
36. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects. Flouvat B; Leneveu A; Fitoussi S; Delhotal-Landes B; Gendron A Int J Clin Pharmacol Ther; 2004 Jan; 42(1):50-7. PubMed ID: 14756388 [TBL] [Abstract][Full Text] [Related]
38. Exposure measures applied to the bioequivalence of two sustained release formulations of bupropion. Midha KK; Rawson MJ; McKay G; Hubbard JW Int J Clin Pharmacol Ther; 2005 May; 43(5):244-54. PubMed ID: 15906590 [TBL] [Abstract][Full Text] [Related]
39. First measured plasma concentration value as C(max); impact on the C(max) confidence interval in bioequivalence studies. Jackson A; Conner D; Miller R Biopharm Drug Dispos; 2000 May; 21(4):139-46. PubMed ID: 11180192 [TBL] [Abstract][Full Text] [Related]
40. Assessment of the bioequivalence of two nelfinavir tablet formulations under fed and fasted conditions in healthy subjects. Kaeser B; Charoin JE; Gerber M; Oxley P; Birnboeck H; Saiedabadi N; Banken L Int J Clin Pharmacol Ther; 2005 Mar; 43(3):154-62. PubMed ID: 15792400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]